Snippet from the article:
An FDA advisory committee has voted against approval of two drugs for the prevention of prostate cancer because of a link to increased risk of high-grade, aggressive forms of the disease.
GlaxoSmithKline’s Avodart and Merck’s Proscar are approved to treat benign prostatic hyperplasia (BPH), or enlarged prostate, which is common among men over the age of 50. In studies, both drugs showed a nearly 25% reduction in the risk of developing low-grade forms of prostate cancer compared to participants taking a placebo.
FDA medical officer Yang-Min Ning, MD, PhD, says such forms of cancer â€œpropose very little threat to men during their lifetime.â€
Read the full text at WebMD — FDA Panel Rejects Drugs to Prevent Prostate Cancer
There is a great deal of politics going on that I really do not understand, but even with this panel rejection, I would not advise my own son to stop taking 1mg finasteride to treat his hair loss.
It is clear that finasteride at the 5mg dose seems to prevent prostate cancer to some degree, but it wasn’t enough for the FDA to label it as a preventive medication for prostate cancer. People will ultimately need to make their own decisions in regards to this medication, but keep in mind that at the 1mg finasteride dose that is prescribed to treat hair loss, there is really no evidence one way or the other that it could be a problem or even if it will prevent prostate cancer. More will be written by other societies and I will fill in the readers of this site once we know where it all “falls out”.